Matching slides 10,656
Current window 6,421-6,450
Pages 356
Rows per page 30
Slide function: Present Frameworkclear collectionreset all

Slide function

6,421-6,450 of 10,656

filter-aware
04
The slide uses a timeline-based process flow to illustrate the clinical trial protocol.argenx SE | Results Presentation Deck | 15 slides · argenx
Conference presentation Investor relations 1 hit
20
The diagram illustrates a randomized clinical trial flow.AstraZeneca | Investor Event Presentation Deck | 42 slides · AstraZeneca
Conference presentation Investor relations Beat · Evidence & Proof1 hit
11
Uses a value-chain style horizontal flow to connect market drivers to strategic outcomes.Azek | Investor Presentation Deck | 37 slides · Azek
Pitch deck Investor relations Beat · SolutionLoop · Quick Win Big Bet1 hit
47
The diagram shows the interaction between tumor cell receptors and iNKT cell receptors, including the secretion of IL15.Mink Therapeutics | Investor Day Presentation Deck | 92 slides · MiNK Therapeutics
Conference presentation Investor relations 1 hit
72
Mink Therapeutics | Investor Day Presentation Deck | 92 slidesMink Therapeutics | Investor Day Presentation Deck | 92 slides · MiNK Therapeutics
Conference presentation Investor relations 1 hit
82
The slide depicts a mechanism of immune evasion via metabolic competition and immunosuppressive signaling.Mink Therapeutics | Investor Day Presentation Deck | 92 slides · MiNK Therapeutics
Conference presentation Investor relations 1 hit
85
The slide depicts a xenograft model setup.Mink Therapeutics | Investor Day Presentation Deck | 92 slides · MiNK Therapeutics
Conference presentation Investor relations 1 hit
30
The slide uses a custom map-based visualization to show operational footprint expansion over time.Oatly | Results Presentation Deck | 33 slides · Oatly
Conference presentation Investor relations Beat · Action1 hit
10
The slide uses a timeline-like structure to show divergence points (300M and 95M years) and compares genetic orthologues.OmniAb | Investor Conference Presentation Deck | 27 slides · OmniAb
Conference presentation Investor relations 1 hit
12
The slide uses a process-flow comparison to highlight the efficiency of the B-cell workflow over the traditional Hybridoma workflow.OmniAb | Investor Conference Presentation Deck | 27 slides · OmniAb
Conference presentation Investor relations 1 hit
19
The slide uses a Gantt-style bar chart to represent the clinical stage of each program.OmniAb | Investor Conference Presentation Deck | 27 slides · OmniAb
Conference presentation Investor relations Loop · Why Now1 hit
05
The slide uses a process flow diagram to explain the core technology offering.OmniAb | Investor Conference Presentation Deck | 43 slides · OmniAb
Conference presentation Investor relations Beat · Problem1 hit
07
The slide uses a process flow framework to categorize proprietary technologies into three distinct stages of the antibody discovery pipeline.OmniAb | Investor Conference Presentation Deck | 43 slides · OmniAb
Conference presentation Investor relations Beat · SolutionLoop · Cost Of Inaction1 hit
10
The slide illustrates the genetic engineering process of replacing endogenous Ig genes with human V gene segments while retaining rodent constant regions for immune robustness.OmniAb | Investor Conference Presentation Deck | 43 slides · OmniAb
Conference presentation Investor relations Beat · SolutionLoop · Cost Of Inaction1 hit
11
Uses a phylogenetic tree to justify the use of avian species for antibody production based on evolutionary divergence.OmniAb | Investor Conference Presentation Deck | 43 slides · OmniAb
Conference presentation Investor relations Beat · SolutionLoop · Cost Of Inaction1 hit
12
The slide compares human and cow antibody structures, specifically focusing on the 'knob-and-stalk' architecture of the ultralong CDRH3.OmniAb | Investor Conference Presentation Deck | 43 slides · OmniAb
Conference presentation Investor relations Beat · SolutionLoop · Cost Of Inaction1 hit
18
The slide uses a process-flow style layout to map inputs (Biological Intelligence) to methods (Computational Tools) and outputs (specific applications).OmniAb | Investor Conference Presentation Deck | 43 slides · OmniAb
Conference presentation Investor relations 1 hit
30
The slide uses a layered visual metaphor to represent value drivers, with the top two rows explicitly showing a multiplicative relationship (New Program Starts x Probability of Success x Standard Deal Terms).OmniAb | Investor Conference Presentation Deck | 43 slides · OmniAb
Conference presentation Investor relations 1 hit
07
The slide uses a bracketed list structure to categorize business models.P3 Health Partners | Investor Conference Presentation Deck | 20 slides · P3 Health Partners
Conference presentation Investor relations 1 hit
06
Uses a custom matrix/grid layout to visualize market penetration and expansion strategy.Paysafe | Results Presentation Deck | 29 slides · Paysafe
Conference presentation Investor relations 1 hit
25
Uses a simple additive framework to explain competitive advantage.Sonos | Results Presentation Deck | 41 slides · Sonos
Conference presentation Investor relations Beat · Action1 hit
28
The slide uses a custom flywheel-style diagram to illustrate the relationship between growth drivers and market conditions.Sonos | Results Presentation Deck | 41 slides · Sonos
Conference presentation Investor relations Beat · Action1 hit
07
The slide uses a biological process diagram to explain the mechanism of action for midodrine and droxidopa in the context of autonomic disorders.Theravance Biopharma | Investor Conference Presentation Deck | 44 slides · Theravance Biopharma
Conference presentation Investor relations Beat · Agitate (Make it worse)Loop · Cost Of Inaction1 hit
09
The slide uses a biological process diagram to explain how different drugs (agonists, precursors, reuptake inhibitors) affect sympathetic signaling to blood vessels.Theravance Biopharma | Investor Conference Presentation Deck | 44 slides · Theravance Biopharma
Conference presentation Investor relations Beat · Agitate (Make it worse)Loop · Cost Of Inaction1 hit
11
The slide uses a process flow diagram to show how patients transition from Study 0169 to 0170.Theravance Biopharma | Investor Conference Presentation Deck | 44 slides · Theravance Biopharma
Conference presentation Investor relations Beat · Solution (Provide relief)1 hit
20
The slide outlines a complex clinical trial structure involving rollovers from Study 0169 and de novo participants, leading into a randomized withdrawal period.Theravance Biopharma | Investor Conference Presentation Deck | 44 slides · Theravance Biopharma
Conference presentation Investor relations 1 hit
21
The slide uses a flow diagram to illustrate study design and participant disposition.Theravance Biopharma | Investor Conference Presentation Deck | 44 slides · Theravance Biopharma
Conference presentation Investor relations 1 hit
34
The slide outlines a clinical trial program involving three studies (0169, 0170, 0171) with specific eligibility criteria and endpoints for a longitudinal analysis.Theravance Biopharma | Investor Conference Presentation Deck | 44 slides · Theravance Biopharma
Conference presentation Investor relations 1 hit
44
The slide uses a tree metaphor for the study name 'CYPRESS'.Theravance Biopharma | Investor Conference Presentation Deck | 44 slides · Theravance Biopharma
Conference presentation Investor relations 1 hit
07
Uses a hub-and-spoke model to show data integration and output.Vivid Seats | Results Presentation Deck | 20 slides · Vivid Seats
Conference presentation Investor relations Beat · NeedLoop · Logic Chain1 hit